Corrigendum to The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate [J Thromb Haemost, 11 (2013) 1540-6]

摘要

Ibrahim S, Jespersen J, Poller L, on behalf of The European Action on Anticoagulation. The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate. J Thromb Haemost 2013; 11: 1540-6. The authors of the above paper wish to make two amendments to their article.' Firstly, they wish to change the OR numbers in the following sentence on page 1543: With the TIR, there was a significantly greater risk of a clinical event in patients with poor INR control (<39%) than in those with excellent INR control (>80%) 6 months before an event (OR 2.12; 95% CI 1.2-3.8, P = 0.01). The paragraph should now read: With the TIR, there was a significantly greater risk of a clinical event in patients with poor INR control (< 39%) than in those with excellent INR control (>80%) 6 months before an event (OR 1.85 (1.1-3.2), P = 0.03). Secondly, also on page 1543, the authors wish to make a change to the following sentence: VGR method A was a significant predictor at 30-month and 6-month intervals prior to an event, with all other measures (TIR and VGR methods Bl and B2) removed from the model. It should read '3-month' and not '30-month'. Therefore, the sentence should now read: VGR method A was a significant predictor at 3-month and 6-month intervals prior to an event, with all other measures (TIR and VGR methods Bl and B2) removed from the model.